3d.FAB platform: 3D printing for life science – Presented by Christophe Marquette, Univ Lyon, Université Lyon1, CNRS, INSA, CPE-Lyon, ICBMS, UMR 5246 at the 3D Bioprinting Conference which takes place on Jan 31, 2017 at MECC Maastricht in The Netherlands.
The 3d.FAB platform of the Lyon1 University, a unique structure in Europe, hosts and drives research projects (private and academic) in the field of health and life science. A large panel of technological offers are available, from FDM to DLP but also bioprinting. Are also available techniques leading to ultra-high resolution using 2 photons printing and ceramic printing. Numerous projects hosted by the platform will be presented with a special focus on cell printing for skin, cartilage, cardiac patches and bone substitute production. 4D printing of hydrogels having biochemical active functions will also be presented together with project dealing with implantable polymer printing.
About Christophe Marquette
Dr Christophe Marquette received the Doctorat de spécialité in Biochemistry (1999) from the Université Claude Bernard-Lyon 1. After a two years post-doctoral fellowship at the Concordia University (Canada, Qc), he integrates the Centre National de la Recherche Scientifique (CNRS) in 2001. He is presently deputy director of the UMR 5246, coordinator of the H2020 project FAPIC (PHC10) and director of French platform 3d.FAB dedicated to the development of additive manufacturing (mainly 3D printing) for health science. Since 1998, he is author of more than 110 publications (H factor 30), 13 chapters, 100 communications and 7 patents, in the field of biology to surface interactions applied to diagnostic and health. He is also the founder of two companies: AXO Science which is commercialising multiplex genotyping systems for blood typing; Nano-H which is specialized in nanoparticles for diagnostic and therapy.
3d.FAB is the only French platform dedicated to academic and private innovation through 3D printing, in the field of health. We have two main areas of expertise:
- For biochemistry, especially diagnosis with prototyping 3D lab-on-chip, novel materials for 3D medical devices, biocompatible polymers and cell-size 3D printing.
- For regenerative medicine through dedicated living cells and tissues printers.
3d.FAB is part of the Biochip group of the UMR5246 (ICBMS) and is host by the Université Lyon1.